EPISODE · Mar 10, 2017 · 3 MIN
Cancer Immunotherapy: CAR T as 'Car Race'
from GEN Podcasts
GEN Sounds of Science March 9, 2017Brad Loncar, CEO of Loncar Investments, weighs in on recent developments in the scramble to develop CAR T cancer immunotherapies. How significant a setback is Juno Therapeutics’ halting development of JCAR015? How could some second-tier companies yet come out on top in the “car race”? Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
Cancer Immunotherapy: CAR T as 'Car Race'
0:00
3:28
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GEN Podcasts?
This episode is 3 minutes long.
When was this GEN Podcasts episode published?
This episode was published on March 10, 2017.
Can I download this GEN Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!